Massively parallel sequencing analysis of mucinous ovarian carcinomas: genomic profiling and differential diagnoses
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 150 (1) , 127-135
Abstract
No abstract availableKeywords
Funding Information
- Marie-Josée and Henry R. Kravis Center for Molecular Oncology
- Cancer Center Support Grant of the National Institutes of Health/National Cancer Institute (P30-CA008748)
This publication has 40 references indexed in Scilit:
- Update on immune checkpoint inhibitors in gynecological cancersJournal of Gynecologic Oncology, 2017
- Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursorsGenome Medicine, 2015
- Mucinous Tumors of the Ovary: Current Thoughts on Diagnosis and ManagementCurrent Oncology Reports, 2014
- Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profilesLaboratory Investigation, 2013
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms: Table 1Journal of Clinical Pathology, 2011
- Immunoprofile of Adenocarcinomas of the Endometrium, Endocervix, and Ovary With Mucinous DifferentiationApplied Immunohistochemistry & Molecular Morphology, 2009
- Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA StudyCancer Epidemiology, Biomarkers & Prevention, 2007
- Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7Laboratory Investigation, 2006
- Mucinous Epithelial Ovarian Cancer: A Separate Entity Requiring Specific TreatmentJournal of Clinical Oncology, 2004